Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
NR5A1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 4 | 1 |
|
Invitae Disorders of Sex Development Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 88 | 53 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
46,XY sex reversal 3, 612965, Autosomal dominant (46,XY complete gonadal dysgenesis) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
PreventionGenetics, part of Exact Sciences United States | 156 | 73 |
|
PreventionGenetics, part of Exact Sciences United States | 128 | 85 |
|
Differences of Sex Development (DSD) Panel PreventionGenetics, part of Exact Sciences United States | 149 | 158 |
|
Differences of Sex Development (DSD) and Infertility Panel PreventionGenetics, part of Exact Sciences United States | 223 | 238 |
|
qGenEx Sex development disorders Quantitative Genomic Medicine Laboratories, SL Spain | 45 | 48 |
|
NR5A1-Related Disorders via the NR5A1 Gene PreventionGenetics, part of Exact Sciences United States | 3 | 1 |
|
Institute for Human Genetics University Medical Center Freiburg Germany | 4 | 1 |
|
Genologica Medica Spain | 25 | 11 |
|
Panel of premature ovarian failure. NGS panel of 15 genes. Genologica Medica Spain | 50 | 15 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.